Celebrating a curious mind: Steven Keating 1988-2019
Steven Keating SM'12, PhD '16 inspired millions with his research-driven approach to battling cancer and his advocacy for open patient health data.
Koch Institute
Unmasking mutant cancer cells
A new dosing regimen for an old cancer drug shows new promise as an immunotherapy.
New vaccine strategy boosts T-cell therapy
Super-charging a treatment for leukemia also makes it effective on solid tumors.
Cancer biologists identify new drug combo
Two drugs that block cell division synergize to kill tumor cells.
Angelika Amon and Dina Katabi named Carnegie Corporation “Great Immigrants”
MIT biologist and electrical engineer are two of 38 naturalized U.S. citizens honored for contributions to American society.
Confining cell-killing treatments to tumors
Attaching a Velcro-like molecule may prevent immune proteins called cytokines from leaking out of cancerous tissue after injection.
A better way to encapsulate islet cells for diabetes treatment
Crystallized drug prevents immune system rejection of transplanted pancreatic islet cells.
Drug makes tumors more susceptible to chemo
Compound that knocks out a DNA repair pathway enhances cisplatin treatment and helps prevent drug-resistance.
Merging machine learning and the life sciences
Through computing, senior and Marshall Scholar Anna Sappington seeks answers to biological questions.
Robert Langer wins 2019 Dreyfus Prize for Chemistry in Support of Human Health
Institute professor is honored for transformative work in drug delivery and tissue engineering.
Measuring chromosome imbalance could clarify cancer prognosis
A study of prostate cancer finds “aneuploid” tumors are more likely to be lethal than tumors with normal chromosome numbers.
Ashwin Sah, Megan Yamoah, and Steven Truong named 2019-20 Goldwater Scholars
Three MIT undergraduates honored for their academic achievements.
3Q: Susan Hockfield on a new age of living machines
Convergence research at MIT and beyond seeks new solutions for global challenges.
A new approach to targeting tumors and tracking their spread
Researchers develop nanosized antibodies that home in on the meshwork of proteins surrounding cancer cells.
Three from MIT elected to the National Academy of Sciences for 2019
Faculty members Edward Boyden, Paula Hammond, and Aviv Regev recognized for “distinguished and continuing achievements in original research.”